New England Journal of Medicine (2025) The REDEFINE 2 Phase 3 trial evaluated CagriSema in 1,206 adults with overweight or obesity and type 2 diabetes in a 68-week, double-blind, placebo-controlled design
305 N-Acetylgalactosamine (GalNAc) Most approved products based on bio-conjugated delivery systems use the GalNAc-coupled delivery system developed by Alnylam Pharmaceuticals
DOI Pollard JD, Quan S, Kang T, Koch RJ
The benefits of Ipamorelin growth hormone Summary: This article states that Ipamorelin increases growth hormone levels by stimulating the hypothalamus, leading to increased muscle mass and strength, as well as fat loss due to increased metabolism and lipolysis
Effects of folic acid supplementation on cognitive impairment: A meta-analysis of randomized controlled trials
Who Can Benefit from IV Vitamin Therapy